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AbstrAct
The Par‑1 protein kinases are conserved from yeast to man and belong to a subfamily 
of kinases that includes the energy sensor and metabolic regulator, AMPK. Par‑1 is 
regulated by LKB1 and atypical PKC and has been shown in multiple organisms and cell 
types to be critical for regulation of cellular polarity. Recent studies using knockout mice 
have revealed several surprising physiological functions for Par‑1b/MARK2/EMK1. Our 
recent study shows that Par‑1b regulates metabolic rate, adiposity and insulin sensitivity. 
This is the first study to implicate these kinases in metabolic functions akin to those previ‑
ously defined for AMPK. Conversely, another series of recent publications now implicate 
AMPK in regulation of polarity. Here we discuss the metabolic phenotype seen in Par‑1b 
deficient mice and the synthesis of several findings that link Par‑1 and AMPK to a degree 
that has not been previously appreciated.
introduction
The	 prototypical	 Par-1	 kinase	 was	 identified	 in	 a	 seminal	 study	 published	 in	 1988	
designed	 to	 identify	 regulators	 of	 early	 embryonic	 polarity	 in	C. elegans.1	 A	 series	 of	
subsequent	 studies	 by	 numerous	 groups	 demonstrated	 that	 Par-1,	 a	 serine/threonine	
protein	 kinase,	 is	 one	 of	 several	 evolutionarily	 conserved	 proteins	 (Par-1,	 Par-3/ASIP,	
Par-4/LKB1,	Par-5/14-3-3,	Par-6	and	atypical	PKC/PKC-3)	required	for	cellular	polarity	
not	only	in	worms	but	also	in	flies,	frogs	and	mammals.2-16	This	body	of	work	has	been	
reviewed	elsewhere.17-20	Studies	done	in	the	context	of	cellular	polarity	demonstrated	that	
Par-1	mediates	at	least	some	of	its	effects	by	phosphorylating	Par-3	and	the	microtubule	
associated	protein	Tau.21-25	Numerous	other	potential	Par-1	substrates	have	been	identified	
including	Cdc25C,	KSR,	Pkp2,	Class	II	HDAC,	Dlg	and	Rab11-FIP.26-32	Interestingly,	
phosphorylation	of	several	Par-1	substrates	leads	to	the	generation	of	phospho-dependent	
14-3-3	 binding.	 Par-1	 substrates	 that	 fall	 into	 this	 category	 include	 Par-3,	 Cdc25C,	
KSR,	Pkp2	and	Class	II	HDAC.	Both	LKB1	(also	known	as	Par-4)	and	atypical	PKCl/i	
(or	PKC-3	in	C. elegans)	regulate	Par-1.	LKB1	phosphorylates	Par-1	and	the	related	AMP	
activated	kinase	AMPK	on	an	activation	loop	Thr	residue.	This	modification	is	required	
for	Par-1	activity.33,34	LKB1	serves	as	a	master	regulator	of	cellular	polarity,	at	least	in	part,	
by	activating	the	Par-1	kinases.16	Atypical	PKC	(aPKC)	phosphorylates	Par-1	to	regulate	
its	 localization	 and	 kinase	 activity.35-37	TAO-1/MARKK	 and	 GSK-3b	 have	 also	 been	
implicated	as	upstream	regulators	of	Par-1.38,39
metAbolic Functions oF Par-1b/mArK2/emK
Physiological	 functions	 of	 the	 mammalian	 Par-1	 kinases	 have	 been	 revealed	 using	
targeted	gene	knockout	approaches	in	mice.	The	mammalian	Par-1	family	is	comprised	of	
four	members	that	go	by	several	names	(Par-1a/MARK3/C-TAK1,	Par-1b/MARK2/EMK,	
Par-1c/MARK1	and	Par-1d).	Four	studies	have	been	published	using	two	independently	
derived	mouse	 lines	null	 for	Par-1b/MARK2/EMK.40-43	These	studies	 implicate	Par-1b	
in	a	diverse	set	of	physiological	processes,	including	fertility,	immune	system	homeostasis,	
learning	and	memory	and	growth	and	metabolism.
Our	most	recent	study	identifies	a	role	for	Par-1b	in	the	regulation	of	metabolism.43	
Par-1b	null	mice	are	growth	retarded	(~20%	reduced	body	mass	relative	to	wild-type)	as	
early	as	E13.5	and	 this	growth	retardation	continues	 throughout	 the	 lifetime	of	Par-1b	
null	 mice.43	Our	 results	 and	 those	 of	 Bessone	 et	 al.	 (1999)	 showing	 decreased	 serum	
IGF-1	 levels	 in	 Par-1b	 null	 mice,	 provide	 a	 reasonable	 explanation	 for	 the	 observed	
www.landesbioscience.com	 Cell	Cycle	 1967
The	Par-1/MARK	Family	of	Protein	Kinases
pre-	and	post-natal	growth	retardation.	Although	a	growth	hormone	
deficiency	 might	 explain	 postnatal	 growth	 differences,	 there	 is	
no	 evidence	 for	 a	 role	 of	 growth	 hormone	 (GH)	 in	 mammalian	
embryonic	 growth,	 suggesting	 that	 Par-1b	 deficiency	 leads	 to	
GH-independent	 growth	defects.	Although	 accurate	 determination	
of	GH	production	is	technically	difficult,	neither	our	study	nor	that	
of	Bessone	et	al.	(1999)	detected	altered	serum	GH	levels	in	Par-1b	
null	mice.
Morphometric	analyses	of	Par-1b	null	mice	revealed	that	although	
most	tissues	are	proportionately	smaller,	knockout	mice	accumulate	
disproportionate	decreases	in	adipose	tissue	(representing	~14%	body	
fat	 in	null	mice	versus	~23%	in	wild-type	mice	at	 twelve	weeks	of	
age).	This	 differential	 is	 slightly	 increased	with	 age	 (18%	body	 fat	
in	 null	mice	 versus	 35%	 fat	 in	wild-type	mice	 at	 one	 year	 of	 age,	
n	 =	 10	 females	 per	 genotype,	 p	 =	 0.002)	 (unpublished	 data).	 In	
addition	to	having	reduced	adiposity,	Par-1b	null	mice	are	resistant	
to	weight	gain	when	placed	on	a	high	 fat	diet	and	are	at	 the	 same	
time	hyperphagic,	eating	twice	that	of	their	wild-type	littermates.	A	
likely	 explanation	 for	 these	 observations	 is	 the	 finding	 that	Par-1b	
null	mice	are	hypermetabolic.	Thus,	resistance	to	weight	gain	due	to	
high	fat	diet	or	increased	caloric	intake	is	due	to	increased	metabolic	
rate.	Although	the	molecular	mechanism	for	these	metabolic	changes	
is	 not	 clear,	 the	 data	 indicates	 that	 loss	 of	 Par-1b	 either	 directly	
or	 indirectly	 increases	 mitochondrial	 function	 in	 adipose	 tissue.	
Intriguingly,	 these	 perturbations	 are	 also	 accompanied	 by	 insulin	
hypersensitivity	and	improved	glucose	tolerance—possibly	the	result	
of	compensatory	changes	that	arise	due	to	a	chronic	hypermetabolic	
state.	Analysis	of	the	relative	levels	of	glucose	uptake	in	muscle	and	
fat	 indicates	that	adipose	tissue	is	most	dramatically	affected	in	the	
absence	of	Par-1b.	White	and	brown	fat	of	Par-1b	null	mice	exhibit	
increased	glucose	uptake	in	both	basal	and	insulin-stimulated	states.
Another	possible	explanation	for	enhanced	insulin	sensitivity	and	
glucose	uptake	in	Par-1b	null	adipose	tissue	is	that	Par-1b	regulates	
GLUT4-mediated	 glucose	 uptake.	 Par-3/ASIP	 studies	 in	 3T3L1	
cells	 indicate	 that	 this	 protein	 (a	 downstream	 target	 of	 Par-1)	 can	
inhibit	insulin	induced	glucose	uptake44	aPKC,	a	negative	regulator	
of	Par-1,	has	been	shown	to	regulate	insulin	triggered	glucose	uptake	
in	multiple	 studies.44,45	 It	 is	unclear	 at	 this	point	how	Par-3/ASIP	
or	aPKC	act	to	regulate	glucose	uptake.	It	is	conceivable	that	aPKC	
influences	 glucose	 uptake	 via	 regulation	 of	 Par-1.	 Par-1	 has	 also	
been	 implicated	 in	 the	 regulation	 of	 vesicular	 trafficking	 via	 the	
exocyst,	which	in	turn	has	been	shown	to	play	a	critical	role	in	the	
transport	 of	 insulin-responsive	 Glut4	 vesicles.46-48	 Regulation	 of	
Rab11-mediated	functions	might	provide	a	mechanistic	explanation	
for	this	model.32,49	Thus,	Par-1	may	be	involved	in	GLUT4-mediated	
glucose	uptake	via	a	mechanism(s)	that	involves	Par-3,	aPKC	and/or	
the	exocyst.
An	 argument	 against	 a	 direct	 role	 for	 Par-1b	 in	 early	 signaling	
events	that	control	Glut4-mediated	glucose	uptake	is	our	finding	that	
insulin	 receptor	 proximal	 signaling	 (IRS-1	 and	AKT	phosphoryla-
tion,	phosphatidylinositol	3-kinase	recruitment)	is	slightly	decreased	
in	 adipose	 tissue	 from	Par-1b	null	mice.	Furthermore,	Zhou	 et	 al.	
(2004)	 reported	 that	 knockdown	 of	 Par-1a	 and/or	 Par-1b	 in	
3T3L1	cells	by	siRNA-treatment,	has	no	effect	on	basal-	or	insulin-	
stimulated	 glucose	 uptake.50	 If	 knockdown	was	 sufficient	 to	 block	
the	function	of	both	Par-1a	and	Par-1b	in	the	3T3L1	system	and	if	
there	 is	not	compensation	by	the	other	two	Par-1	family	members,	
then	this	data	provides	an	argument	against	a	direct	role	for	Par-1	in	
Glut4-mediated	glucose	uptake.	Even	 if	Par-1	regulates	 the	activity	
of	Glut4	downstream	of	AKT,	 this	 function	would	not	completely	
explain	our	observation	of	hypermetabolism	and	 reduced	adiposity	
in	 the	 Par-1b	 null	 mice	 because	 adipose-specific	 overexpression	
of	 Glut4	 alone	 leads	 to	 enhanced	 glucose	 uptake	 in	 combination	
with	 increased	 adiposity	 (not	 decreased	 adiposity	 as	 observed	 in	
Par-1b	deficiency).51-53	Future	 studies	using	 tissue-specific	deletion	
of	Par-1b	in	adipose	tissue	will	elucidate	the	contribution	made	by	
adipose	tissue	to	these	phenotypes.
There	is	also	a	significant	body	of	literature	describing	a	role	for	
Par-1	in	neuronal	cell	polarity.31,54-56	Several	interesting	possibilities,	
including	regulation	of	the	hypothalamic-pituitary-adrenergic	axis	of	
the	neuronal	system	by	Par-1b,	might	explain	the	observed	metabolic	
changes	 in	 Par-1b	 null	 mice.57	 Again,	 tissue-specific	 deletion	 of	
Par-1b	 in	the	nervous	system	should	clarify	how	this	compartment	
contributes	to	the	observed	phenotypes.
AmPK And PAr-1: PArtners in PolArity And metAbolism?
Based	 on	 sequence	 similarities	 (50%	 identity	 across	 their	
kinase	 domains),	 AMPK	 and	 Par-1	 are	 closely	 related	 members	
of	 a	 subfamily	 that	 also	 includes	 BRSK1/2,	 QIK	 and	 SIK.58	
Conservation	of	the	kinase	domains	of	these	proteins	suggests	similar	
phosphorylation-site	 preferences.	 Alignment	 of	 several	 known	
substrates	 indicates	 that	Par-1	and	AMPK	prefer	 to	phoshorylate	a	
serine	residue	when	Leu/Ile/Met,	Arg/Lys,	and	Leu	are	present	in	the	
-5,	-3	and	+4	positions,	respectively	(Fig.	1).	In	addition	to	sharing	
a	common	consensus	phosphorylation	motif,	both	AMPK	and	Par-1	
family	members	are	activated	by	LKB1.34	Interestingly,	recent	studies	
indicate	that	Par-1b	and	AMPK	have	overlapping	functions	in	vivo.	
As	 mentioned	 above,	 Par-1	 has	 historically	 been	 associated	 with	
regulating	 polarity,	 while	 AMPK	 has	 been	 studied	 for	many	 years	
in	 the	 context	 of	 energy	 sensing	 and	 metabolism.	 The	 metabolic	
Figure 1. Par‑1 and AMPK substrates share a common phosphorylation 
consensus sequence. Sequences inclusive of and surrounding the phosphory‑
lation site of several Par‑1 and AMPK substrates are aligned. Phosphorylated 
serine residues are highlighted in blue and preferred residues in the ‑5, ‑3 
and +4 positions are highlighted in yellow. h, human; d, Drosophila; KSR, 
kinase suppressor of Ras; PKP2, Plakophilin, ACC1, acetyl CoA carboxylase; 
TORC2, transducer of regulated cAMP response element‑binding protein 
(CREB); PFK2, phospho‑fructo‑kinase; TSC2, tuberous sclerosis; GS, glycogen 
synthase; NOS, nitric oxide synthase; HMG‑CoA, 3‑hydroxy‑3‑methylglutaryl‑ 
coenzyme A reductase.
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functions	 of	AMPK	have	 been	well-reviewed	 elsewhere.59,60	These	
functions	 include	 inhibition	 of	 fatty	 acid,	 glycogen	 and	 protein	
synthesis	 and	 activation	of	 glucose	uptake	 (in	 skeletal	muscle)	 and	
glycolysis	in	response	to	cellular	energy	stress	(increased	AMP	levels).	
Our	study	now	elucidates	a	role	for	Par-1b	in	metabolic	regulation,	
potentially	via	an	adipose-	and/or	a	neuronal-specific	mechanism(s).	
At	the	same	time,	four	recent	studies	have	uncovered	a	role	for	AMPK	
in	the	regulation	of	polarity.61-64	It	is	therefore	tempting	to	speculate	
that	Par-1	and	AMPK	share	either	a	common	and/or	complementary	
set	of	substrates	that	act	to	regulate	similar	biological	processes.
concluding remArKs
Recent	studies	using	Par-1b	null	mice	demonstrate	that	mammalian	
Par-1b/MARK2	is	required	for	multiple	physiological	processes	that	
could	 not	 have	 been	 predicted	 from	 previous	 studies	 conducted	
in	 vitro.	 Our	 recent	 work	 indicates	 that	 Par-1b	 is	 important	 for	
metabolic	 regulation,	 and	 in	 particular,	 adiposity.	 Perhaps	 not	
surprising,	a	combination	of	studies	has	now	drawn	several	parallels	
between	substrate	specificities,	upstream	regulators	and	physiological	
functions	of	Par-1	 and	AMPK.	Although	 their	 kinase	domains	 are	
clearly	 related	 in	 sequence,	 the	 notion	 that	 the	 functions	 of	 Par-1	
and	AMPK	in	polarity	and	metabolism,	respectively,	might	be	over-
lapping,	was	 not	 predicted.	Many	 exciting	 questions	 remain	 to	 be	
answered,	including	the	identification	of	downstream	substrates	and	
upstream	regulators	of	Par-1	and	AMPK	with	respect	to	their	newly	
defined	 functions	 as	 well	 as	 the	 identification	 of	 tissues	 that	 are	
relevant	to	the	observed	metabolic	defects	in	Par-1b	null	mice.
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